About University of Vermont , Department of Neurology Given Building C-219 , 89 Beaumont Avenue
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at University of Vermont , Department of Neurology Given Building C-219 , 89 Beaumont Avenue
During the past decade, University of Vermont , Department of Neurology Given Building C-219 , 89 Beaumont Avenue conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Vermont , Department of Neurology Given Building C-219 , 89 Beaumont Avenue"
#1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "University of Rochester" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at University of Vermont , Department of Neurology Given Building C-219 , 89 Beaumont Avenue
According to Clinical.Site data, the most researched conditions in "University of Vermont , Department of Neurology Given Building C-219 , 89 Beaumont Avenue" are
"Multiple Sclerosis, Relapsing-Remitting" (1 trials), "Parkinson Disease" (1 trials), "Parkinson's Disease" (1 trials) and "Relapsing-remitting Multiple Sclerosis" (1 trials). Many other conditions were trialed in "University of Vermont , Department of Neurology Given Building C-219 , 89 Beaumont Avenue" in a lesser frequency.
Clinical Trials Intervention Types at University of Vermont , Department of Neurology Given Building C-219 , 89 Beaumont Avenue
Most popular intervention types in "University of Vermont , Department of Neurology Given Building C-219 , 89 Beaumont Avenue" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Albumin (Human) 25%, United States Pharmacopeia (USP)" (1 trials), "Coenzyme Q10 with vitamin E" (1 trials), "Copaxone®" (1 trials), "Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified" (1 trials) and "Rebif®" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of Vermont , Department of Neurology Given Building C-219 , 89 Beaumont Avenue
The vast majority of trials in "University of Vermont , Department of Neurology Given Building C-219 , 89 Beaumont Avenue" are
4 trials for "All" genders.
Clinical Trials Status at University of Vermont , Department of Neurology Given Building C-219 , 89 Beaumont Avenue
Currently, there are NaN active trials in "University of Vermont , Department of Neurology Given Building C-219 , 89 Beaumont Avenue".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in University of Vermont , Department of Neurology Given Building C-219 , 89 Beaumont Avenue,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in University of Vermont , Department of Neurology Given Building C-219 , 89 Beaumont Avenue, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".